These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 12185047)

  • 21. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
    Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
    Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison between short-interval and regular-interval follow-up for BI-RADS category 3 lesions.
    Ruamsup S; Wiratkapun C; Wibulpolprasert B; Lertsithichai P
    Singapore Med J; 2010 Feb; 51(2):120-5. PubMed ID: 20358150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical application of the BI-RADS final assessment to breast sonography in conjunction with mammography.
    Kim EK; Ko KH; Oh KK; Kwak JY; You JK; Kim MJ; Park BW
    AJR Am J Roentgenol; 2008 May; 190(5):1209-15. PubMed ID: 18430833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of benignity or malignancy of a lesion using BI-RADS.
    Masroor I
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):686-8. PubMed ID: 16300702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
    Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
    Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect on biopsy technique of the breast imaging reporting and data system (BI-RADS) for nonpalpable mammographic abnormalities.
    Ball CG; Butchart M; MacFarlane JK
    Can J Surg; 2002 Aug; 45(4):259-63. PubMed ID: 12174979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
    Hoorntje LE; Peeters PH; Mali WP; Borel Rinkes IH
    Breast Cancer Res Treat; 2004 Jul; 86(2):165-70. PubMed ID: 15319568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammographic surveillance after MammoSite breast brachytherapy: analysis of architectural patterns and additional interventions.
    Dragun AE; Jenrette JM; Ackerman SJ; Irshad A; Pope TL
    Am J Clin Oncol; 2007 Dec; 30(6):574-9. PubMed ID: 18091050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment and Management of Challenging BI-RADS Category 3 Mammographic Lesions.
    Michaels AY; Birdwell RL; Chung CS; Frost EP; Giess CS
    Radiographics; 2016; 36(5):1261-72. PubMed ID: 27541437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3).
    Gruber R; Jaromi S; Rudas M; Pfarl G; Riedl CC; Flöry D; Graf O; Sickles EA; Helbich TH
    Eur J Radiol; 2013 Mar; 82(3):398-403. PubMed ID: 22429299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.
    Baum JK; Hanna LG; Acharyya S; Mahoney MC; Conant EF; Bassett LW; Pisano ED
    Radiology; 2011 Jul; 260(1):61-7. PubMed ID: 21502382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.
    Barr RG; Zhang Z; Cormack JB; Mendelson EB; Berg WA
    Radiology; 2013 Dec; 269(3):701-12. PubMed ID: 23962417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.
    Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    Br J Radiol; 2018 Jul; 91(1087):20170787. PubMed ID: 29658793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].
    Graf O; Helbich TH; Fuchsjäger MH; Hopf G; Morgun M; Graf C; Mallek R
    Rofo; 2004 Sep; 176(9):1251-6. PubMed ID: 15346259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammographic characteristics and vacuum-assisted breast biopsy (VABB) of non-palpable breast lesions.
    Ventrella V; Tufaro A; Zito FA; Addante M; Stea B; Dentamaro R; D'Amico C; Paradiso A
    Acta Radiol; 2011 Jul; 52(6):602-7. PubMed ID: 21565889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast tomosynthesis for the clarification of mammographic BI-RADS 3 lesions can decrease follow-up examinations and enables immediate cancer diagnosis.
    Bahrs SD; Otto V; Hattermann V; Klumpp B; Hahn M; Nikolaou K; Siegmann-Luz K
    Acta Radiol; 2018 Oct; 59(10):1176-1183. PubMed ID: 29451022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?
    Graf O; Helbich TH; Fuchsjaeger MH; Hopf G; Morgun M; Graf C; Mallek R; Sickles EA
    Radiology; 2004 Dec; 233(3):850-6. PubMed ID: 15486217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms.
    Lehman C; Holt S; Peacock S; White E; Urban N
    AJR Am J Roentgenol; 2002 Jul; 179(1):15-20. PubMed ID: 12076896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.